Bookmark
Forward
Explore Literature Results
Explore Clinical Trials Results
QuickView for PHA
Most Relevant Literature
- PHA-680626 Is an Effective Inhibitor of the Interaction between Aurora-A and N-Myc.
- Metabolic engineering of Methylorubrum extorquens AM1 for poly (3-hydroxybutyrate-co-3-hydroxyvalera…
- Identification and characterization of novel proteins associated with CHD4.
- Chromodomain helicase DNA-binding 4 (CHD4) regulates early B cell identity and V(D)J recombination.
- Assessment of a Line Immunoassay for the Detection of Mi-2 Antibodies: Results From a Single Academi…
Most Relevant Clinical Trials
- Extension Study of Oral PHA-022121 for Acute Treatment of Angioedema Attacks in Patients With Heredi…
- A Study To Evaluate The Dose Response And Safety Of PHA-794428 In Adults With Growth Hormone Deficie…
- Dose-ranging Study of Oral PHA-022121 for Acute Treatment of Angioedema Attacks in Patients With Her…
- Phase II Study Of Oral PHA-848125AC In Patients With Thymic Carcinoma
- A Single Dose Study to Evaluate the PK-PD Response and Safety of PHA-794428 in Children With Growth …
